TY  - JOUR
N1  - Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/730)
TI  - CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS
N2  - In patients with diabetes mellitus type 2, non-insulin antihyperglycemic therapy is aimed to control symptoms of hyperglycemia and to limit microvascular complications. It is introduced early after diagnosis of the disease. Antihyperglycemic agents may predominantly act through one of four ways. The involved mechanisms are: enhancement of insulin secretion, through which act sulfonylureas, meglitinides and two types of incretin mimetics - glucagon-like peptide-1 (GLP-1) receptor agonists and inhibitors of dipeptidyl peptidase-4 (DPP-4) activity -gliptins; suppression of hepatic glucose production - biguanides; enhanced sensitivity to insulin - thiazolidinediones, and decrease of the rate or extent of glucose absorption: islet amyloid polypeptide (amylin) analogs and ?-glucosidase inhibitors. With exception of GLP-1 receptor agonists and pramlintide, a synthetic form of amylin, all these drugs are administered orally.
PB  - Center for Tech and Media Research
JF  - Multidisciplinary Journal of Science and Technology
ID  - arxiv52936
Y1  - 2024/01/20/
UR  - https://mjstjournal.com/index.php/mjst/article/view/730
KW  - complex
KW  -  diabetes
KW  -  pharmacogical
KW  -  insulin
KW  - Glucose-lowering agent Guidelines
KW  -  Pharmacotherapy
KW  -  Type 2 diabetes
AV  - none
A1  - o'g'li, Rayimnazarov Shaxzot Muhiddin
A1  - o'g'li, Abduraxmonov Alijon Shodmon
A1  - Yuldashevich, Chariev Muzaffar
ER  -